Search research articles
Contact Us
Filters
Showing results (531-540 of 786) with videos related to
Page
of 79
Sort By:
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Cell
|
September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Eric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)
Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Journal of Medicinal Chemistry
|
September 16, 2024
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Yiyun Yu, Miyeon Jang, Julie Miyashiro, et al.
ACS Medicinal Chemistry Letters
|
October 16, 2020
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> Inhibitor
Le Wang, George A Doherty, Andrew S Judd, et al.
Physical Review Letters
|
July 5, 2002
Search for nu(mu)-->nu(e) and nu(mu)-->nu(e) oscillations at NuTeV
S Avvakumov, T Adams, A Alton, et al.
Physical Review Letters
|
July 20, 2001
Observation of an anomalous number of dimuon events in a high energy neutrino beam
T Adams, A Alton, S Avvakumov, et al.
Physical Review Letters
|
August 11, 2001
Search for the lepton family number violating process nu(mu)e(-) --> mu(-)nu(e)
J A Formaggio, J Yu, T Adams, et al.
Physical Review Letters
|
February 28, 2002
Precise determination of electroweak parameters in neutrino-nucleon scattering
G P Zeller, K S McFarland, T Adams, et al.
Physical Review Letters
|
September 16, 2000
High-precision measurement of the left-right Z Boson cross-section asymmetry
K Abe, K Abe, T Abe, et al.
Page
of 79
Search research articles
Search
Showing results (531-540 of 786) with videos related to
Sort By:
Page
of 79
Journal of Medicinal Chemistry
|
September 16, 2005
Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Yujia Dai, Yan Guo, Robin R Frey, et al.
Cell
|
September 5, 2024
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Eric M Mucker, Alec W Freyn, Sandra L Bixler, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)
Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Journal of Medicinal Chemistry
|
September 16, 2024
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Yiyun Yu, Miyeon Jang, Julie Miyashiro, et al.
ACS Medicinal Chemistry Letters
|
October 16, 2020
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X<sub>L</sub> Inhibitor
Le Wang, George A Doherty, Andrew S Judd, et al.
Physical Review Letters
|
July 5, 2002
Search for nu(mu)-->nu(e) and nu(mu)-->nu(e) oscillations at NuTeV
S Avvakumov, T Adams, A Alton, et al.
Physical Review Letters
|
July 20, 2001
Observation of an anomalous number of dimuon events in a high energy neutrino beam
T Adams, A Alton, S Avvakumov, et al.
Physical Review Letters
|
August 11, 2001
Search for the lepton family number violating process nu(mu)e(-) --> mu(-)nu(e)
J A Formaggio, J Yu, T Adams, et al.
Physical Review Letters
|
February 28, 2002
Precise determination of electroweak parameters in neutrino-nucleon scattering
G P Zeller, K S McFarland, T Adams, et al.
Physical Review Letters
|
September 16, 2000
High-precision measurement of the left-right Z Boson cross-section asymmetry
K Abe, K Abe, T Abe, et al.
Page
of 79